In light of these intricate interconnections, it is plausible that LRRC37A2, through its involvement in the pathological processes of Parkinson's disease and breast cancer, may directly or indirectly impact bone metabolism, which may explain the genetic link between LRRC37A2 and BMD. Here, LRRC37A2 is linked to breast carcinoma.